April 23, 2025

Sense of Belonging 'Critical' for Workplace Retention

Individuals who reported a neutral level of satisfaction with their sense of belonging were approximately 3 times more likely to express an intent to leave, while those who were dissatisfied were 7 times more likely to do so, compared to individuals who were satisfied with their sense of belonging.

Conexiant

April 21, 2025

Risk-Free Midlife: 10+ Years Longer Living

Prioritizing the prevention and treatment of the modifiable risk factors could substantially extend healthy life expectancy worldwide.

Conexiant

April 16, 2025

CONSORT 2025: Setting New Standards for Clinical Trial Reporting

"Readers should not have to infer what was probably done; they should be told explicitly." This principle drives the comprehensive CONSORT 2025 update, with its 7 new checklist items aimed at improving clinical trial transparency.

Conexiant

April 15, 2025

Mavacamten Misses Endpoints in nHCM Trial

Mavacamten's phase III trial for nonobstructive hypertrophic cardiomyopathy does not show significant improvement in functional capacity or symptoms, reflecting challenges in less severe populations. Bristol Myers Squibb plans to present full data at a future scientific meeting.

Reuters

April 09, 2025

Daytime Eating Protects Night Shift Hearts

Restricting meals to daytime hours may reduce cardiovascular changes during simulated night shifts.

Conexiant

April 04, 2025

Warning Signs Before Sudden Cardiac Death

New research identified key clinical indicators that precede sudden arrhythmic death syndrome in patients under 36.

Conexiant

March 31, 2025

Tariff Threat: Drugs Could Cost U.S. $750M More

New research reveals 25% tariffs on Canadian pharmaceuticals would impact critical medications, strain supply chains, and potentially increase costs—with 28 drugs having no alternative suppliers.

Conexiant

March 28, 2025

FDA Declines Cardamyst Approval Request

The FDA declined to approve Milestone’s etripamil nasal spray for PSVT, citing manufacturing issues and a need for more data on impurities, but raised no safety or efficacy concerns.

Reuters

February 01, 2023

Heart Rhythm Disorders: The Newest Devices, Procedures and Research Projects

The newest devices, procedures and research projects are paving new paths for patients with heart rhythm disorders like atrial fibrillation and ventricular arrhythmias

Cedars-Sinai Pulse